1980
DOI: 10.1038/bjc.1980.147
|View full text |Cite
|
Sign up to set email alerts
|

The diagnostic value of circulating trophoblast-specific β1-glycoprotein (TSG) in cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
1
0

Year Published

1983
1983
1989
1989

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 10 publications
1
1
0
Order By: Relevance
“…For patients with breast cancer the SP1 concentration was of the same level as that in women with benign tumours. No values above 3 pgl-1 were found which agreed with other studies (Bremmer et al, 1981;Rosen et al, 1982), but conflicted with studies previously reported to have from 22% to 29% of SP1 determinations >>3ygl-' (Searle et al, 1978;Wurz, 1979) and 8% to 11% >l0pgI-' (Wiirz, 1979;Tatarinov, 1980). In a less sensitive assay with a detection limit of lOpgl-1, SP1 was observed in only one of 42 patients with malignant breast disorders (Grudzinskas et al, 1980).…”
supporting
confidence: 68%
See 1 more Smart Citation
“…For patients with breast cancer the SP1 concentration was of the same level as that in women with benign tumours. No values above 3 pgl-1 were found which agreed with other studies (Bremmer et al, 1981;Rosen et al, 1982), but conflicted with studies previously reported to have from 22% to 29% of SP1 determinations >>3ygl-' (Searle et al, 1978;Wurz, 1979) and 8% to 11% >l0pgI-' (Wiirz, 1979;Tatarinov, 1980). In a less sensitive assay with a detection limit of lOpgl-1, SP1 was observed in only one of 42 patients with malignant breast disorders (Grudzinskas et al, 1980).…”
supporting
confidence: 68%
“…However, SP1 does not seem to be specific to pregnancy since it has been detected by radioimmunoassay in sera from 3 to 54% of healthy persons (Searle et al, 1978;Wurz, 1979;Tatarinov, 1980) and in sera from patients with a variety of malignant diseases, for instance 8-55% of breast cancer patients (Searle et al, 1978;Wiirz, 1979;Tatarinov, 1980), depending on the detection limit of the assay. By means of a histological immunoperoxidase technique SP1 has been demonstrated in 37-76% of malignant tumours of the breast (Horne et al, 1976;Inaba et al, 1980;Walker, 1981).…”
mentioning
confidence: 99%